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Abstract. Dose-dependent ffects of intravenously admin- 
istered lorazepam on haemodynamic fluctuations were 
studied by means of spectral analysis, in order to eluci- 
date sympathetic and parasympathetic components in
cardiovascular control during situations of rest and men- 
tal stress after benzodiazepine administration. I  a dou- 
ble-blind randomized cross-over study, nine male volun- 
teers participated in two sessions: a placebo and lo- 
razepam session. During these sessions, the subjects re- 
peatedly performed a 10-rain version of the Stroop Color 
Word Test (CWT), with 10 min of rest between the CWTs. 
Lorazepam was administered before each rest period in 
increasing doses of 0.0, 0.06, 0.13, 0.25 and 0.5 mg (total 
cumulative dose: 0.94 mg). During the placebo session 
the subjects received five placebo injections. For five of 
the nine subjects the lorazepam session was their first 
session. Heat rate (HR), blood pressure (BP) and respira- 
tion were recorded continuously. Power spectra were cal- 
culated per 2.5-min periods for HR, systolic (SBP) and 
diastolic BP (DBP). Spectral density was assessed for 
three frequency bands: low (LFB: 0.02-0.06 Hz), mid 
(MFB: 0.07 0.14 Hz) and high (HFB: 0.15-0.40 Hz). 
During the consecutive periods of rest, lorazepam in- 
duced a dose-dependent decrease in HR, and a dose-de- 
pendent increase in LFB, MFB and HFB power of HR, 
but lorazepam had no effect on BP. The effects were sig- 
nificant after 0.44 mg lorazepam for HR and HFB power, 
and after 0.94 mg lorazepam for the HR fluctuations in
the LFB and MFB. Lorazepam did not influence the 
cardiovascular responses to the CWT. Our data under- 
line that benzodiazepines can exert a specific influence on 
parasympathetic activity: lorazepam induced dose-de- 
pendent increases in cardiac vagal tone, resulting in de- 
creased HR and increased HR variability, but only dur- 
ing periods of rest. The increase in vagal tone observed 
after low doses of lorazepam was not related to dimin- 
ished sympathetic activity, altered respiration, or in- 
creased sedation. 
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Benzodiazepines are th preferred rugs in the treatment 
of anxiety symptoms inpatients with cardiovascular dys- 
function. The effects of benzodiazepines on autonomic 
cardiovascular control mechanisms in man have been 
studied and interpreted primarily in relation to sym- 
pathetic nervous system activity (Duka et al. 1986; 
Marty et al. 1986; Roy-Byrne et al. 1988; Tulen et al. 
1991) and not to parasympathetic mechanisms. 
Normal vagal (parasympathetic) cardiac control has 
been associated with good health (Eckberg 1980). Since 
EPStein et al. (1973) observed that in patients with an 
acute myocardial infarction the vagal tone to the heart 
exerts a significant protective ffect against lethal ventri- 
cular arrhythmias, a careful evaluation of the vagolytic 
or vagomimetic properties of anxiolytic drugs seems 
warranted. Animal research has suggested that ben- 
zodiazepines can affect cardiac vagal tone by means of 
GABA-ergic inhibitory mechanisms (DiMicco 1987). 
Analysis of variation patterns in cardiovascular pa- 
rameters such as heart rate (HR) or blood pressure (BP) 
offers one approach to obtaining non-invasive indices of 
cardiac parasympathetic activity. Previous research as 
shown that breathing linked variations in HR reflect a 
parasympathetic influence on the heart by means of al- 
terations in cardiac vagal inhibition (Higgins et al. 1973; 
Katona and Jih 1975; Eckberg 1985). In a recent study 
by Adinoffet al. (1992) cardiac vagal tone, as determined 
by quantifying the amplitude of the respiratory sinus 
arrhythmia, was found to decrease after intravenous 
administration f diazepam. This finding in human sub- 
jects therefore indicates a specific parasympathetic effect 
of benzodiazepines, but further studies in human subjects 
are needed to substantiate his. 
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Previously, we have reported the dose-response effects 
(dose range: 0.0-0.94 rag) of cumulative intravenous 
doses oflorazepam on sympathetic nervous ystem activ- 
ity and psychological parameters (Tulen et al. 1991). We 
observed a significant decrease in heart rate at low doses 
of lorazepam (EDs0:0.13 rag) during periods of rest, 
whereas sedation and suppression of sympathetic pa- 
rameters occurred at a significantly higher cumulative 
dose of 0.94 rag. We suggested that this may reflect an 
increase in vagal stimulation of the heart, but were un- 
able to substantiate his. We have now analyzed the data 
of the above mentioned experiment by means of spectral 
analysis of beat to beat fluctuations in HR and BP. With 
this method three spectral peaks are usually defined with- 
in a time segment of several minutes (Sayers 1973; Aksel- 
rod et al. 1981, 1985): 
1. A low frequency peak with variations around 0.04 Hz; 
for HR this peak is associated with both parasympathetic 
and sympathetic activity (Akselrod et al. 1985), while 
these low-frequency BP fluctuations are linked to varia- 
tions in peripheral vasomotor activity due to thermo- 
regulatory influences (Kitney 1975) or renin-angio- 
tensin system activity (Akselrod et al. 1985). 
2. A mid frequency peak with variations around 0.1 Hz 
(Mayer waves) which has been associated with changes 
in sympathetic tone (Pagani et al. 1986), or with a re- 
sonance in the baroreflex control of peripheral resistance 
(Wesseling and Settels 1985; Madwed et al. 1989). 
3. A high frequency peak around the respiratory fre- 
quency, usually between 0.20 and 0.35 Hz, which for HR 
represents centrally mediated vagal (parasympathetic) 
activity (Angelone and Coulter 1964; Davies and Nielson 
1967). For BP these fluctuations may result from cen- 
trally mediated HR fluctuations (Akselrod et al. 1985), 
although the mechanical effects of respiration may also 
contribute substantially to these fluctuations (Saul et al. 
1991). 
This means that spectral analysis can be employed to 
obtain non-invasive stimates of both sympathetic and 
parasympathetic a tivity within short-term cardiovas- 
cular control, and as such it may extend our insight into 
the effects of benzodiazepines on autonomic nervous 
system activity during various situations of rest or stress 
and anxiety. Beat to beat fluctuations in HR and BP are 
now widely studied to quantify parasympathetic and 
sympathetic influences within the complex neural control 
of short-term homeostatic cardiovascular p ocesses (i.e. 
Akselrod et al. 1981, 1985; Yongue et al. 1982; Pomeranz 
et al. 1985; Malliani et al. 1991). In addition to these 
analyses of cardiovascular variability, we also analyzed 
baroreflex sensitivity according to the method described 
by Robbe et al. (1987). 
The Stroop Color Word Test (CWT) was used in 
order to compare the effects of lorazepam during periods 
of rest and during periods of increased HR and BP due 
to mental stress as induced by the CWT (Frankenhaeuser 
and Johansson 1976; Hjemdahl et al. 1984; Tulen et al. 
1989, 1991). 
Materials and methods 
Subjects. Nine male volunteers (mean age: 23.9 years; range: 21-29) 
each participated in two sessions in a randomized double-blind 
cross-over study, after they had given written informed consent. 
The study procedures and protocol were approved by the Medical 
Ethical Committee of the University Hospital Rotterdam Dijkzigt. 
The screening procedure included a medical examination to exclude 
subjects with cardiorespiratory abnormalities. A l subjects were in 
good physical condition. Subjects with a history of alcohol or drug 
abuse were excluded from the study. 
Design, procedure and measurements. Details of the procedures have 
been presented before (Tuien et al. 1991). During both sessions, the 
subjects performed on five consecutive occasions a 10-rain version 
of the Stroop Color Word Test (CWT), with 10 rain of rest between 
the CWTs. The CWT consists of four words (red, green, blue, 
yellow) which are presented onvideotape, one word at a time, in 
four different colors (red, green, blue, yellow). The subject has to 
indicate the color of the word on an answer sheet, with the specific 
request to do his best and make as few errors as possible. The test 
induces cognitive conflict (Stroop 1935), while time-pressure eff cts 
are added due to the rapid presentation of the stimuli (on average 
one word per 1.5-2 s). In order to become familiar with the require- 
ments of the task, a 2-min practice tape was presented at the 
beginning of the first session f rinstruction purposes. 
During one session (the placebo or PLA session), an intravenous 
PLA injection (2.5 ml saline, slowly injected over 1 min) wasad- 
ministered five times, each time before the r st periods. During the 
other session (the lorazepam or LOR session), LOR was adminis- 
tered intravenously (in 2.5 ml saline, slowly injected over 1 min) 
before each rest period in increasing doses of 0.0, 0.0625, 0.125, 0.25 
and 0.5 mg (total cumulative dose: 0.9375 mg). The two sessions per 
subject were recorded on separate days, 1 week apart. Five of the 
nine subjects received lorazepam during their first session. Each 
session lasted from 09 : 00 to 12:30 hours. Physiological, biochemi- 
cal and psychological measurements were obtained while the 
subjects were seated in a comfortable armchair during the entire 
recording. 
Forty-five minutes before the start of the recordings, a catheter 
Venflon, 18G, Viggo AB, Helsingborg, Sweden) wasinserted into 
an antecubital vein of the non-dominant forearm, through which 
blood samples were drawn and infusions of LOR/PLA were given. 
Blood samples for assay of lorazepam concentrations were obtained 
15 rain after the injections (i.e. during the second half of each CWT: 
the last 5 min). Blood wascollected in heparinized tubes; the tubes 
were immediately placed on ice and centrifuged within 15 min after 
collection. Plasma w s subsequently frozen at - 70 ° C. Lorazepam 
was assayed with a high-performance liquid chromatographic 
method according to Brodie et al. (1978), with the following modifi- 
cations: extraction with dichloromethane and a methanol/ammo- 
nium phosphate buffer (50/50) was used for elution of the column. 
ECG, blood pressure and respiration were recorded continuous- 
ly during the sessions on an FM-type analogue recorder (Racal 
Store 14 DS, Sarasota, Fla., USA) for off-line analyses bycom- 
puter. The ECG was derived using a precordial lead, amplified by 
means of a polygraph (Nihon Kohden, Tokyo, Japan). Blood pres- 
sure was recorded using a servo-plethysmomanometer for con- 
tinuous non-invasive measurement of finger arterial blood pressure, 
employing the volume clamp technique of Pefifiz(Pefi~z et al. 1976; 
Settels and Wesseling 1985) (Finapres 2300 NIBP monitor, Oh- 
meda, Englewood, Col., USA). The cuffed middle finger of the 
non-dominant hand was kept at the level of the heart by means of 
a supportive arm-rest, in order t  optimize the correspondence with 
intrabrachial pressure changes (Parati et al. 1989). Thoracic and 
abdominal respiration were measured separately by means of im- 
pedance plethysmographs (Nihon Kohden, Tokyo, Japan). Ad- 
hesive disposable Ag/AgC1 electrodes (Red Dot, Medical Products 
Devision, 3M, St Paul, USA) were used for the thoracic and 
abdominal respiration recordings, placed at the level of the nipples 
and the abdomen, r spectively. 
Analyses. The ECG and blood pressure signals were digitized at a 
sample frequency of 1024 Hz on a Personal Computer (Commodore 
PC 60-III) connected to an Analogue/Digital converter (Advantech 
PC-LabCard model PCL-718). R-R intervals in the ECG were 
detected with an accuracy of 1 ms and transposed toheart rate (HR) 
series. Systolic and diastolic blood pressure (SBP, DBP) were de- 
fined per R-R interval of the ECG, with an accuracy of 0.1 mmHg. 
For prolonged blood pressure recordings, the Finapres device has 
the facility of a built-in "lock-adjust" procedure for automatic 
adjustment of the finger cuff pressure by means of a servo system, 
which is activated in parallel with blood flow changes. This 
procedure takes place very 40-70 beats under stationary con- 
ditions. Since a total session in this study could last up to 3 h, we 
employed this procedure to prevent slow drifts and unreliable re- 
cordings. As a result, every 40-70 beats, 2-4 pulses were missing 
from the blood pressure recording. By means of a linear interpola- 
tion between two preceding and two succeeding pulses the missing 
values were estimated, while a small amount of additional noise 
(0.25 SD) was added in order to prevent a temporary excessive 
reduction i  variability due to the correction procedure itself (Muld- 
er 1988). In addition, time-series ofHR, SBP and DBP were scruti- 
nized for stationarity and artifacts by means of visual inspection. 
One blood pressure r cording showed technical shortcomings and
was not analyzed. The thoracic respiratory signal was sampled with 
a frequency of 102.4 Hz. 
For each recording, the consecutive 10-min periods of rest were 
analyzed, in addition to the first 5 rain of each CWT. 
Spectral analysis of heart rate and blood pressure. Within each 
period of rest or CWT, consecutive time segments of 2.5 min of HR, 
SBP and DBP time series were subjected to a discrete Fourier 
transform, based on on-equidistant sampling of the R-wave in- 
cidences (CARSPAN program, Mulder et al. 1988). With this meth- 
od power spectral densities of rhythmic oscillations over a fre- 
quency range of 0.02-0.50 Hz were obtained, with a frequency 
resolution of 0.01 Hz. For each time segment, power density was 
calculated for the total band (0.02-0.50 Hz), low frequency band 
(LFB: 0.02-0.06 Hz), mid frequency band (MFB: 0.07 0.14 Hz) 
and high frequency band (HFB: 0.15-0.40 Hz), in addition to mean 
HR, SBP and DBP, and variation coefficients (VC) of HR, SBP and 
DBP. Spectral energy was expressed in relative terms, i.e. in nor- 
malized values relative to the mean value of the considered signal 
(squared modulation i dex, to be compared with squared variation 
coefficient; Van Dellen et al. 1985). Because the total power equals 
the squared variation coefficient minus the low frequency DC com- 
ponent, total power data are not presented, but variation coef- 
ficients are. For the spectral data a logarithmic transformation was 
performed because of skewness of the distributions. As an index of 
baroreflex sensitivity (BRS), we computed per time segment the gain 
(or modulus) in the MFB between the systolic pressure values and 
the R-R interval times, based on those frequency points within the 
0.07-0.14 Hz range with a coherence between the two signals of 
greater than or equal to 0.5 (Robbe et al. t987). 
The results of the analysis of the consecutive time segments 
(2.5-rain periods) were averaged per rest or CWT period, because 
we observed no systematic trends within the concecutive time seg- 
ments. This procedure reduced a noise factor due to spontaneous 
segment to segment fluctuations and allowed a statistical nalysis 
of the dose- or time-dependent changes within the sessions. 
Respiration. Mean (SEM) respiratory cycle duration (in seconds) 
and inspiratory depth (in percentage ofchange versus baseline times 
100) were calculated per period of rest or CWT, on the basis of 
analysis of the thoracic respiratory signal. In addition, respiratory 
irregularities were quantified by computing the number of sighs 
(amplitude increase by a factor of 2, versus the mean amplitude of 
the previous 30 respiratory cycles) or hypopnoeas (amplitude de- 
crease by a factor of 0.5) per period of rest or CWT. 
Statistical nalyses. Data will be presented as mean (SEM) for n = 9 
with the exception f the blood pressure analyses (n = 8). Similarity 
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of the baseline values of the two sessions was evaluated, per param- 
eter, by means of t-tests for pairwise comparisons. Our analyses 
were focused at describing the dose-dependent effects during the 
LOR session, with the PLA session as a mere control. Therefore, 
MANOVAs for repeated measurements were performed for each 
condition separately. For the LOR condition, MANOVAs were 
used to establish the effect of the CWT versus the rest periods 
(within-subject Factor Stress: rest/CWT), the five doses of LOR 
(within-subject Factor Dose: five consecutive rest and CWT 
periods) and the interaction between factors Stress and Dose (re- 
flecting the effect of increasing doses of lorazepam on the conse- 
cutive CWT responses, i.e. the CWT response magnitudes versus 
the preceding rest periods). For the PLA condition, the MANOVAs 
were employed to establish the effect of the CWT versus the rest 
periods (within-subject Factor Stress: rest/CWT), the time-depen- 
dency or habituation effects (within-subject Factor Time: five 
consecutive r st and CWT periods) and the interaction effect be- 
tween factors Stress and Time (reflecting habituation effects in the 
consecutive CWT response magnitudes). If a significant main effect 
or interaction effect was observed, Duncan's multiple range tests 
were used in order to search for specific dose- or time-related ffects. 
A P-value of <0.05 was used to indicate a significant effect. 
Results 
Plasma concentrations of lorazepam 
The p lasma LOR concentrat ions were propor t iona l  to 
the cumulat ive dose administered (Table 1). 
Cardiovascular variability 
For  each cardiovascular  parameter ,  baseline values of  
the PLA  and LOR session were similar (P>0.05;  NS). 
Heart rate (HR).  The CWT signif icantly increased HR 
and significantly decreased HR VC and f luctuations in 
the LFB,  MFB and HFB dur ing both the PLA  and the 
LOR session (Tables 2, 3, Fig. 1). Dur ing the PLA  ses- 
sion, the CWT response magnitudes howed no habitua-  
t ion during the five consecutive CWT presentat ions (no 
significant interact ion effects, Table 2); significant ime- 
dependent trends were only observed for the LFB  fluc- 
tuations, showing a small gradual  increase in power  
during the entire session (Table 2, Fig. 1). LOR induced 
a significant dose-dependent  decrease in HR,  while HR 
VC and LFB,  MFB and HFB f luctuations increased 
dose-dependent ly  (Table 2, Fig. 1, 3). Since no significant 
interact ion effects between factors Stress and Dose for 
HR and LFB,  MFB and HFB f luctuations were ob- 
served, it can be concluded that the resting values were 
affected by the increasing doses of  LOR,  while the re- 
sponse magnitudes to the consecutive CWTs  remained 
the same. After  a cumulat ive dose o f  0.44 mg LOR,  HR 
decreased and HFB f luctuations increased signif icantly 
compared  with the first rest period. After a cumulat ive 
dose of  0.94 mg LOR,  HR VC and f luctuations in LFB  
and MFB were significantly increased compared  with the 
first rest period. 
Systolic blood pressure (SBP). The CWT signif icantly 
increased SBP, and significantly decreased SBP VC and 
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Table 1. Mean (SEM) plasma concentrations of lorazepam after 
cumulative doses of LOR 
Dose Cumulative Plasma LOR 
(rag) dose (rag) (ng/ml) 
0 0 0 
0.0625 0.0625 3.56 (0.44) 
0.125 0.1875 6.22 (0.52) 
0.25 0.4375 14.56 (3.54) 
0.5 0.9375 20.00 (0.91) 
LFB and MFB power during both the PLA and the LOR 
sessions (Table 2, 3, Fig. 2). During the PLA session, the 
fluctuations in the HFB were not significantly affected by 
the CWT (P = 0.09, NS), but LOR significantly decreased 
HFB fluctuations during the CWT. During both sessions 
a significant decrease in the consecutive SBP CWT re- 
sponse magnitudes was observed (interaction effects sig- 
nificant), indicating learning or habituation effects to the 
CWT, but no drug-specific effects. During the PLA ses- 
sion we observed a time-dependent i crease in SBP, which 
was not present during the LOR session (Table 2, Fig. 
2). This increase in SBP during the PLA session was 
accompanied by a significant time-dependent decrease in 
VC and LFB fluctuations. LOR did not influence the 
CWT response magnitudes of SBP VC, and LFB, MFB 
and HFB fluctuations; these CWT responses also 
showed no habituation effects during the consecutive 
presentations (Table 2). 
Diastolic blood pressure (DBP). The CWT significantly 
increased DBP and significantly decreased DBP VC and 
LFB, MFB and HFB fluctuations during both the PLA 
and the LOR session (Tables 2, 3). As with SBP, DBP 
increased time-dependently during the PLA session, 
while the consecutive CWT response magnitudes showed 
a habituation effect during both the PLA and the LOR 
session. The LFB fluctuations increased ose-dependent- 
ly during the LOR-session (Tables 2, 3) due to a gradual 
increase in LFB power during the rest periods. 
Baroreflex sensitivity. BRS decreased significantly during 
the CWTs of both the PLA and the LOR session (Tables 
2, 4). The response magnitudes to the consecutive CWTs 
showed no time- or dose-dependent effects. However, 
during the LOR session the BRS levels during the rest 
periods increased ose-dependently; after a cumulative 
dose of 0.44 mg LOR, BRS was significantly increased 
compared with the first rest period. 
Resp~at~n 
Respiratory cycle duration decreased significantly during 
the CWTs of the PLA and the LOR session (Tables 2, 
4). During the PLA session this was accompanied by a 
significant reduction in respiratory depth; for the LOR 
session there was a trend towards significance (Table 2, 
P=0.07,  NS). The number of sighs or hypopnoeas 
showed no systematic hanges during the PLA or the 
LOR session because of highly variable data. Response 
magnitudes of the consecutive CWTs were not affected 
by LOR or PLA, for all the respiratory parameters mea- 
sured. 
Table 2. F-values and level of significancies of the MANOVAs for repeated measurements, for he placebo (PLA) and lorazepam (LOR) 
sessions separately. * P < 0.05, ** P < 0.01, *** P < 0.001 
Placebo Lorazepam 
Stress Time Stress x Time Stress Dose Stress × Dose 
(rest/CWY) (CWTresponse) (rest/CWT) (CWTresponse) 
HR 12.82"* 1.40 0.37 16.67"* 12.04"** 0.96 
VC HR 29.54*** 1.69 1.72 59.57*** 15.23"** 3.82** 
LFB HR 25.87*** 2.90* 0.45 37.83*** 13.45"** 0.58 
MFB HR 42.52*** 1.61 2.43 24.83*** 8.68*** 1.36 
HFB HR 11.81"* 0.74 1.10 34.04*** 10.85"** 0.67 
SBP 12.39"* 4.60** 3.15* 11.95"* 0.53 7.13"** 
VC SBP 7.77* 5.12"* 0.11 22.86** 1.70 0.44 
LFB SBP 21.35"* 4.98** 1.05 98.70*** 0.38 0.04 
MFB SBP 15.53"* 0.96 0.50 17.48"* 0.34 0.40 
HFB SBP 3.78 1.89 1.24 39.26*** 0.99 1.32 
DBP 16.92"* 5.68** 5.04** 32.06*** 0.94 4.34** 
VC DBP 13.42"* 1.08 0.13 18.00"* 2.03 0.27 
LFB DBP 17.03"* 0.62 0.60 54.66*** 3.35* 0.18 
MFB DBP 58.54*** 2.36 0.15 27.53*** 0.15 0.36 
HFB DBP 05.87* 0.33 2.50 15.30** 0.88 0.48 
BRS 10.89"* 0.57 1.05 12.88"* 7.14"* 0.78 
Resp. cycle 15.75"* 0.68 0.95 28.38*** 1.49 0.93 
Resp. depth 6.60* 1.48 1.08 4.39 0.21 0.35 
Sighs 2.97 2.60* 1.09 0.75 2.00 1.01 
Hypopnoeas 0.04 2.00 0.99 0.45 0.83 0.55 
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Discussion 
Although a limited number of subjects (n = 9) were incor- 
porated in this study an interesting aspect of the mecha- 
nism of action of lorazepam was revealed by our data, 
indicating a specific parasympathetic effect after low 
doses of this benzodiazepine. 
Cardiovascular variability durin9 rest 
Previously, we suggested that the observed decrease in 
HR might indicate a stimulating effect of LOR on car- 
diac vagal tone during rest (Tulen et al. 1991). The 
present dose-dependent increases in BRS, and LFB, 
MFB, and HFB power of HR and the absence of changes 
in BP variability lend direct support to this hypothesis. 
It has been shown that high, mid and low frequency 
fluctuations in HR can be influenced by parasympathetic 
mechanisms during situations of rest (Akselrod et al. 
1985; Pomeranz et al. 1985) and the increase in BRS may 
also be the result of parasympathetic stimulation (Eck- 
berg et al. 1971). 
Adinoff et al. (1992) reported an opposite effect in a 
similar, although not placebo-controlled, research proto- 
col in healthy subjects after intravenous administration 
of diazepam: a dose-dependent increase in HR and a 
dose-dependent attenuation of cardiac vagal tone. Al- 
though their and our data underline an effect of ben- 
zodiazepines on cardiac vagal tone, the direction of the 
effect clearly is not similar for all benzodiazepines. In our 
design, we additionally used repeated presentations of 
the CWT between the rest periods: it cannot be excluded 
that rebound phenomena due to the strain of the tasks 
influenced the responses during periods of rest. However, 
pharmacokinetic differences between diazepam and 
lorazepam may be more relevant for the interpretation 
of these experiments. We have chosen lorazepam because 
it has a short distribution half-life and no active metab- 
olites, which in combination with an elimination half-life 
of 12-13 h makes cumulative dose administration pos- 
sible. This assumption is supported by our pharmaco- 
kinetic data (Table 1). Diazepam, on the other hand, is 
much more lipophilic, which will result in high brain 
concentrations immediately after intravenous ad- 
ministration and a swift decrease within minutes. In 
mice, for example it has been shown that diazepam con- 
centration in the brain is reduced tenfold between 10 and 
30 min after intravenous administration, whereas 
lorazepam concentrations were rather constant during 
the first hour after administration (Greenblatt and Sethy 
1990). Adinoff et al. (1992) do not present plasma data 
of diazepam and its active metabolites, nor do they 
present data on respiratory or sedative effects of 
diazepam, which could explain the effects on vagal tone. 
However, the opposite results obtained with diazepam 
and lorazepam can only be clarified when both drugs are 
compared within the same experiment. Opposite effects 
on cardiac vagal activity of two different GABA-ergic 
systems have been described (Wible and DiMicco 1986) 
and, although benzodiazepines may not necessarily be 
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involved, similar opposite mechanisms cannot be ex- 
cluded for benzodiazepines. 
The observed increase in vagal tone induced by LOR 
could be caused by respiratory effects. Benzodiazepines 
are known to cause respiratory depression, especially 
after intravenous administration of high doses (Dan- 
neberg 1986; Berggren et al. 1987). Regarding LOR, a 
lack of respiratory effects (Gasser et al. 1975; Elliott et 
al. 1971), respiratory stimulation (Paulson et al. 1983; 
Dodson et al. 1976), or respiratory inhibition (Wettstein 
et al. 1990) have been reported. In this study with low 
doses, LOR did not induce clear respiratory effects on the 
parameters measured, indicating that the cardiac effects 
cannot be explained by changes in respiration. 
Sedative ffects of lorazepam, mediated by suppres- 
sion of locus coeruleus firing (Grant et al. 1980) might 
also explain the observed effects on HR, BRS and HR 
fluctuations. Previously, we have shown that after the 
highest cumulative dose (0.94 mg), LOR induced signifi- 
cant sedative ffects as indicated by performance impair- 
ment, increased fatigue and decreased vigor (Tulen et al. 
1991). After the highest dose plasma noradrenaline con- 
centrations were also lowered in comparison with the 
PLA session, reflecting a suppression of sympathetic 
nervous ystem activity, but only after the highest dose 
of LOR. HR, HFB fluctuations and BRS already 
changed significantly after 0.44 mg LOR; MFB and 
LFB fluctuations changed significantly after 0.94 mg 
LOR. Thus, the effects of LOR at the lower doses do not 
appear to be related to sedation. 
Overall, the present data indicate a stimulating effect 
of LOR on cardiac parasympathetic a tivity during 
periods of rest. 
Cardiovascular variability to the Stroop Color Word 
Test (CWT) 
The CWT significantly increased HR, SBP, DBP and 
respiration rate and significantly decreased BRS, respi- 
ratory depth and LFB and MFB fluctuations in HR, 
SBP and DBP as well as HFB fluctuations in HR and 
DBP. LOR did not induce clear effects on the variability 
responses to the CWT. The SBP and DBP response 
magnitudes to the CWTs showed a habituation effect 
during both sessions; the other parameters showed sim- 
ilar response magnitudes to the five consecutive CWTs. 
Our results of decreased HR and BP variability in the 
three frequency bands during a mental task correspond 
with findings of others (Mulder and Mulder 1981; 
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Veldman et al. 1985; Langewitz and R/iddel 1989). Sim- 
ilarly, a reduction in BRS during psychological stress has 
been observed in a number of studies, in which BRS 
during mental stress was computed either after applica- 
tion of a pressor agent (Sleight et al. 1978; Conway et al. 
1983), the neck suction method (Ditto and France 1990), 
or by means of non-invasive methods (Robbe et al. 1987; 
Steptoe and Sawada 1989; Pagani et al. 1991). Overall, 
the reduced variability in HR and BP during the CWT 
resembles a pattern of a parasympathetic withdrawal 
(Akselrod etal.  1985; Pomeranz et, al. 1985). However, 
previously we have established that the CWT induces 
a defence-like reaction by means of sympatho- 
adrenomedullary activation; the CWT increased HR, 
plasma and urinary adrenaline, electrodermal ctivity 
and muscular tension, whereas it decreased finger pulse 
amplitude (Tulen et al. 1989). The present study does not 
permit differentiation between parasympathetic with- 
drawal, sympathetic activation, or both, as a possible 
cause for the changes in cardiovascular variability ob- 
served during the CWT. It is clear, however, that LOR 
had no effect on these cardiovascular responses to the 
CWT, although performance of the task deteriorated 
severely after the highest dose (0.94 mg LOR), apparent- 
ly due to the sedative ffects of LOR (Tulen et al. 1991). 
In conclusion, in this study, we observed a specific 
effect of LOR on parasympathetic activity: LOR induced 
dose-dependent i creases in cardiac vagal tone. This effect 
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of LOR was apparent only during periods of rest and, at 
low doses, appeared not to be related to diminished 
sympathetic activity, altered respiration, or increased 
sedation. These data show that spectral analysis of beat 
to beat fluctuations in HR and BP represents a useful 
tool to elucidate sympathetic and parasympathetic activ- 
ity within cardiovascular control mechanisms after ben- 
zodiazepine administration• This approach is valuable 
for our insight into the effects of benzodiazepines on 
autonomic nervous system activity during various situa- 
tions of rest or stress and anxiety. 
Acknowledgements. The authors would like to thank Drs. V.J.H.M. 
van den Heuij (Department of Psychiatry) for the analyses of the 
respiratory parameters, and Dr. L.J.M. Mulder and Dr. A.M. van 
Roon (Experimental and Occupational Psychology, University of 
Groningen) for providing the software for the analysis of cardiovas- 
cular variations. Dr. J. Huisman (Pharmacological Laboratory, 
Psychiatric Centre "Zon en Schild', Amersfoort) performed the 
lorazepam assays. 
References 
Adinoff B, Mefford I, Waxman R, Linnoila M (1992) Vagal tone 
decreases following intravenous diazepam. Psychiatry Res 
41 : 89-97 
Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen 
RJ (1981) Power spectrum analysis of heart rate fluctuation: 
a quantitative probe of beat-to-beat cardiovascular control. 
Science 213: 220-222 
Akselrod S, Gordon D, Mahwed JB, Snidman NC, Shannon DC, 
Cohen RJ (1985) Hemodynamic regulation: investigation by 
spectral analysis. Am J Physiol 249:H867-H875 
Angelone A, Coulter NA (1964) Respiratory and sinus arrhythmia: 
a frequency dependent phenomena. J Appl Physiol 19:479-482 
Berggren L, Eriksson I, Mollenholt P, Sunzel M (1987) Changes 
in respiratory pattern after repeated doses of diazepam and 
midazolam in healthy subjects. Acta Anaesthesiol Scand 
31 : 667-672 
Brodie RR, Chasseaud LF, Taylor T (1978) High-performance 
liquid chromatographic determination of benzodiazepines in
human plasma. J Chromatogr 150:361-366 
Conway J, Boon N, Vann Jones J, Sleight P (1983) Involvement of 
the baroreceptor eflexes in the changes in blood pressure with 
sleep and mental arousal. Hypertension 5:746-748 
Danneberg P (1986) Effects of brotizolam and other diazepines on 
respiration. Arzneiminelforschung 36: 610-615 
Davies CTM, Nielson JMM (1967) Sinus arrhythmia in man at rest. 
J Appl Physiol 22:947 955 
DiMicco JA (1987) Evidence for control of cardiac vagal tone by 
benzodiazepine r ceptors. Neuropharmacology 26:553-559 
Ditto B, France C (1990) Carotid baroreflex sensitivity at rest and 
during psychological stress in offspring of hypertensives and 
non-twin sibling pairs. Psychosom Med 52:610-620 
Dodson ME, Yousseff Y, Maddison S, Pleuvry B (1976) Respirat- 
ory effects of lorazepam. Br J Anaesth 48:611-612 
Duka T, Ackenheil M, Noderer J, Doenicke A, Dorow R (1986) 
Changes in noradrenaline plasma levels and behavioural re- 
sponses induced by benzodiazepine agonists with the ben- 
zodiazepine antagonist Ro 15-1788. Psychopharmacology 
90:351-357 
Eckberg DL (1980) Parasympathetic ardiac control in human 
disease: a critical review of methods and results. Am J Physiol 
239: H581-H593 
Eckberg DL (1983) Human sinus arrhythmia as an index of vagal 
cardiac outflow. J Appl Physiol 54:961-966 
89 
Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac 
parasympathetic control in patients with heart disease. N Engl 
J Med 285:877-883 
Elliott HW, Nomof N, Navarro G, Ruelius HW, Knowles JA, 
Comer WH (1971) Central nervous ystem and cardiovascular 
effects of lorazepam in man. Clin Pharmacol Ther 12:468-481 
Epstein SE, Goldstein RE, Redwood DR (1973) The early phase of 
acute myocardial infarction: Pharmacological aspects of 
therapy. Ann Int Med 78 : 918-936 
Frankenhaeuser M, Johansson G (1976) Task demand as reflected 
in catecholamine excretion and heart ate. J Hum Stress 2: 15-23 
Gasser JC, Kaufman RD, Bellville JW (1975) Respiratory effects of 
lorazepam, pentobarbital, and pentazocine. Clin Pharmacol 
Ther 18:170 174 
Grant S J, Huang YH, Redmond DE (1980) Benzodiazepines at- 
tenuate single unit activity in the locus coeruleus. Life Sci 
27: 2231-2236 
Greenblatt DJ, Sethy VH (1990) Benzodiazepine concentrations in 
brain directly reflect receptor occupancy: studies of diazepam, 
lorazepam and oxazepam. Psychopharmacology 102:373 378 
Higgins CB, Vatner SF, Braunwald E (1973) Parasympathetic con- 
trol of the heart. Pharmacol Rev 25:119-155 
Hjemdahl P, Freyschuss U, Juhlin-Dannfelt A, Linde B (1984) 
Differentiated sympathetic activation during mental stress 
evoked by the Stroop test. Acta Physiol Scand Suppl 527 : 25-29 
Katona PG, Jib R (1975) Respiratory sinus arrhythmia: a nonin- 
vasive measure of parasympathetic cardiac control. J Appl 
Physiol 39:801-805 
Kitney RI (1975) Entrainment of the human RR interval by thermal 
stimuli. J Physiol Lond 252:37P-38P 
Langewitz W, Riiddel H (1989) Spectral analysis of heart rate 
variability under mental stress. J Hypertens, 7[suppl 6] : $32-$33 
Madwed JB, Albrecht P, Mark RG, Cohen RJ (1989) Low- 
frequency oscillations in arterial pressure and heart rate: a 
simple computer model. Am J Physiol 25: H 1573-H 1579 
Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovas- 
cular neural regulation explored in the frequency domain. Cir- 
culation 84:482-492 
Marty J, Gauzit R, Lefevre P, Couderc E, Farinotti R, Henzel C, 
Desmonts JM (1986) Effects of diazepam and midazolam on 
baroreflex control of heart rate and on sympathetic a tivity in 
humans. Anesth Analg 65 : 113-119 
Mulder G, Mulder LJM (1981) Information processing and car- 
diovascular control. Psychophysiology 18: 392-402 
Mulder LJM (1988) Assessment of cardiovascular reactivity by 
means of spectral analysis. PhD Thesis, University Press, Un- 
iversity of Groningen 
Mulder LJM, van Dellen H J, van der Meulen P, Opheikens B (1988) 
CARSPAN : a spectral analysis program for cardiovascular time 
series. In: Maarse FJ, Mulder LJM, Sjouw W, Akkerman A 
(eds) Computers in psychology: methods, instrumentation a d 
psychodiagnostics. Swets and Zeitlinger, Lisse, pp 30-38 
Pagani M, Lombardi F, Guzetti S, Rimoldi O, Furlan R, Pizzinelli 
P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, 
Baselli G, Cerutti S, Malliani A (1986) Power spectral analysis 
of heart rate variability and arterial pressure variabilities as a 
marker of sympathovagal interaction in man and conscious 
dogs. Circ Res 59:178 193 
Pagani M, Rimoldi O, Pizzinelli P, Furlan R, Crivellaro W, Liberati 
D, Cerutti S, Malliani A (1991) Assessment ofthe neural control 
of the circulation during psychological stress. J Auton Nerv Syst 
35 : 33~42 
Parati G, Casadei R, Gropelli A, Di Rienzo M, Mancia G (1989) 
Comparison of finger and intraarterial b ood pressure monitor- 
ing at rest and during laboratory testing. Hypertension 
3 : 647 655 
Paulson BA, Becker LD, Way WL (1983) The effects of intravenous 
lorazepam alone and with meperidine on ventilation in man. 
Acta Anaesthesiol Seand 27:400-402 
Penaz J, Voigt A, Teichmann W (1976) Beitrag zur fortlaufenden 
indirekten Blutdruckmessung. Zschr Inn Med 31:1030-1033 
Pomeranz B, Macaulay R J, Caudill MA, Kutz I, Adam D, Gordon 
D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson 
H (1985) Assessment ofautonomic function in humans by heart 
rate spectral analysis. Am J Physiol 17:H151-H153 
Robbe HWJ, Mulder LJM, Riiddel H, Veldman JBP, Langewitz 
WA, Mulder G (1987) Assessment of baroreftex sensitivity by 
means of spectral analysis. Hypertension 10:538-543 
Roy-Byrne PP, Lewis N, Villacres C, Greenblatt DJ, Shader RI, 
Veith RC (1988) Suppression ofnorepinephrine appearance rate 
in plasma by diazepam in humans. Life Sci 43:1615-1623 
Saul JP, Berger RD, Albracht P, Stein SP, Chen MH, Cohen RJ 
(1991) Transfer function analysis of the circulation: unique 
insights into cardiovascular egulation. Am J Physiol 
261 :H1231-H1245 
Sayers B (1973) Analysis of heart rate variability. Ergonomics 
16:17-32 
Settels JJ, Wesseling KH (1985) Fin.A.Pres: non-invasive finger 
arterial pressure waveform registration. In: Orlebeke JF, 
Mulder G, van Doornen LJP (eds) Psychophysiology of car- 
diovascular control. Plenum Press, New York, pp:267-283 
Sleight P, Fox P, Lopez R, Brooks DE (1978) The effect of mental 
arithmetic on blood pressure variability and baroreflex sen- 
sitivity in man. Clin Sci Molec Med 55:381s-382s 
Steptoe A, Sawada Y (1989) Assessment of baroreceptor reflex 
function during mental stress and relaxation. Psychophysiology 
26:140-147 
Stroop JR (1935) Interference in serial verbal reactions. J Exp 
Psychol 18: 643-661 
Tulen JHM, Moleman P, van Steenis HG, Boomsma F (1989) 
Characterization f stress reactions to the Stroop Color Word 
Test. Pharmacol Biochem Behav 32:9-15 
Tulen JHM, Moleman P, Boomsma F, Van Steenis HG, Van den 
Heuij VJHM (1991) Dose-dependent effects of intravenous 
lorazepam on cardiovascular ctivity, plasma catecholamines 
and psychological function during rest and mental stress. Psy- 
chopharmacology 105:77-83 
Van Dellen HJ, Aasman J, Mulder LJM, Mulder G (1985) Time 
domain versus frequency domain measures of heart rate vari- 
ability. In: Orlebeke JF, Mulder G, van Doornen LJP (eds) 
Psychophysiology of cardiovascular control. Plenum Press, 
New York, pp 353-374 
Veldman JBP, Mulder LJM, Mulder G, Van der Heide D (1985) 
Short-term coherence between blood pressure and heart-rate 
during mental loading: an exploration in the time- and fre- 
quency domain. In: Orlebeke JF, Mulder G, Van Doornen LJP 
(eds) Psychophysiology of cardiovascular control. Plenum 
Press, New York, pp 391-405 
Wesseling KH, Settels JJ (1985) Baromodulation explains hort- 
term blood pressure variability. In: Orlebeke JF, Mulder G, van 
Doornen LJP (eds) Psychophysiology of cardiovascular control. 
Models, methods and data. Plenum Press, New York, pp 69-97 
Wettstein JG, Teeple ES, Morse WH (1990) Respiratory effects 
of benzodiazepine-related drugs in awake rhesus monkeys. 
J Pharmacol Exp Ther 255:1328-1334 
Wible JH, DiMicco JA (1986) Biphasic effects of systemically ad- 
ministered GABA antagonists on cardiac vagal activity. Brain 
Res 363 : 279-289 
Yongue BG, McCabe PM, Porges SW, Rivera ME, Kelley SL, 
Ackles PK (1982) The effects of pharmacological manipula- 
tions that influence vagal control of the heart period, heart- 
period variability and respiration in rats. Psychophysiology 
19:426-432 
